BIOMAT Database Logo BIOMAT Database Logo

[Prevention of postoperative venous thrombosis with small doses of subcutaneous heparin]. 1977

M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger

UI MeSH Term Description Entries
D007279 Injections, Subcutaneous Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin. Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
[Postoperative thrombosis. Prevention with small doses of subcutaneous heparin].
December 1972, La Nouvelle presse medicale,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Prevention of venous thrombosis with small, subcutaneous doses of heparin.
May 1976, JAMA,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Small doses of subcutaneous heparin and postoperative deep venous thrombosis.
January 1973, Lancet (London, England),
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Small doses of subcutaneous heparin and postoperative deep venous thrombosis.
November 1972, Lancet (London, England),
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Small subcutaneous doses of heparin in prevention of venous thrombosis.
March 1973, The New England journal of medicine,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Small doses of subcutaneous heparin in preventing postoperative deep venous thrombosis.
February 1974, American heart journal,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
[Letter: Prevention of venous thrombosis--embolism in patients with small subcutaneous doses of heparin].
May 1976, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
[Prophylaxis of postoperative venous thrombosis by subcutaneous heparin administered in small doses. Recent findings].
January 1975, Anesthesie, analgesie, reanimation,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
[Prevention of postoperative deep vein thrombosis with small doses of heparin].
January 1974, Duodecim; laaketieteellinen aikakauskirja,
M Kraytman, and M Kutnowski, and J Ansay, and M Vandendris, and R Fastrez, and R Steinberger
Small doses of heparin in the prevention of deep venous thrombosis.
August 1971, Lancet (London, England),
Copied contents to your clipboard!